SCHEMBL2861907

SCHEMBL2861907

CCCCCC(=O)N(Cc1ccc(C#Cc2ccc(CCCC)cc2)cc1)Cc1ccc(C(=O)OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
CYP4A11 Q02928 2/20 0.48
CYP4F2 P78329 1/20 0.47
PLK1 P53350 1/20 0.45
LPAR1 Q92633 1/20 0.44
LPAR5 Q9H1C0 1/20 0.44
PTPN11 Q06124 1/20 0.43
PTPRO Q16827 1/20 0.43
MDH1 P40925 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13711780 0.90 RARB (0.51) PDE6DHDAC3HDAC1HDAC2HDAC6
SCHEMBL5162625 0.89 HDAC1 (0.58) PDE6DHDAC3HDAC1HDAC2HDAC6
SCHEMBL5162616 0.88 PDE6D (0.58) PDE6DHDAC3HDAC1HDAC2HDAC6
SCHEMBL2854924 0.87 RARB (0.55) HDAC3HDAC1HDAC2HDAC6NCOR2
SCHEMBL1813169 0.87 CYP4A11 (0.62) CYP4A11CYP4F2PLK1PTPN11MDH1
SCHEMBL2875007 0.86 SLC6A4 (0.43) PDE6DHDAC3HDAC1HDAC2HDAC6
SCHEMBL2858113 0.84 PTPN11 (0.47) HDAC3HDAC1HDAC2HDAC6NCOR2
SCHEMBL2858345 0.81 CA1 (0.47) HDAC1HDAC6CYP4A11CYP4F2PLK1
SCHEMBL1734728 0.81 LTB4R2 (0.53) LPAR1PTPN11PTPROFFAR1FFAR4
SCHEMBL2853542 0.81 CYP4A11 (0.55) CYP4A11CYP4F2PLK1PTPN11MDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS PDE6D 3890/4885HDAC3 425/4885HDAC1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.